investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Breast Cancer Genomics in Windows of Susceptibility to Endocrine Disruptors
Susan L Teitelbaum
2 Collaborator(s)
Funding source
National Institute of Environmental Health Sciences (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Jia Chen
Icahn School of Medicine at Mount Sinai
New York, United States
Susan L Teitelbaum
Icahn School of Medicine at Mount Sinai
New York, United States
Fiorella Belpoggi
Ramazzini Institute
Bentivoglio, Italy
Related projects
Philip N Tsichlis
The role of IWS1 in development and tumorigenesis
Breast
Mien-Chie Hung
Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation
Breast
Susan Bates
Clinical Studies to Circumvent Drug Resistance
Breast
Dario Marchetti
Functional characterization of brain-colonizing breast cancer CTC subsets
Breast
Bert W O'Malley
Sex Hormone Receptor Components and the Cell Genome
Breast
Lalage Wakefield
Development of TGF-beta antagonists for cancer therapy
Breast
Stuart Keith Calderwood
Extracellular Hsp70 and hyperthermia in tumor therapy
Breast
Nathanael S Gray
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Breast
Lisa M Coussens
Regulating the Immune Microenvironment in Breast Cancer
Breast